Ebos Group (ASX:EBO) Short Percentage of Float


ASX:EBO Ebos Group Ltd ASX:EBO
77 GF Score
Price A$16.76
GF Value A$31.49
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ebos Group Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:EBO vs MCK, COR, CAH: Short Percentage of Float Comparison

For the Medical Distribution subindustry, Ebos Group's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ebos Group Short Percentage of Float vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Ebos Group's Short Percentage of Float falls into.


ASX:EBO
77GF Score
Ebos Group Ltd ASX:EBO
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ebos Group (ASX:EBO) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49. GuruFocus considers Ebos Group to be Significantly Undervalued.

Key valuation signals for ASX:EBO:

  • Short Percentage of Float:
  • GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ebos Group Business Description

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score

Get the complete analysis for ASX:EBO

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$16.76
Price
A$31.49
GF Value